132 related articles for article (PubMed ID: 9512200)
1. Psychological responses to the needle-free Medi-Jector or the multidose Disetronic injection pen in human growth hormone therapy.
Verrips GH; Hirasing RA; Fekkes M; Vogels T; Verloove-Vanhorick SP; Delemarre-Van de Waal HA
Acta Paediatr; 1998 Feb; 87(2):154-8. PubMed ID: 9512200
[TBL] [Abstract][Full Text] [Related]
2. The Medi-Jector II: efficacy and acceptability in insulin-dependent diabetic patients with and without needle phobia.
Houtzagers CM; Visser AP; Berntzen PA; Heine RJ; van der Veen EA
Diabet Med; 1988 Mar; 5(2):135-8. PubMed ID: 2964978
[TBL] [Abstract][Full Text] [Related]
3. Local tolerance, pharmacokinetics, and dynamics of ganirelix (Orgalutran) administration by Medi-Jector compared to conventional needle injections.
Oberyé J; Mannaerts B; Huisman J; Timmer C
Hum Reprod; 2000 Feb; 15(2):245-9. PubMed ID: 10655292
[TBL] [Abstract][Full Text] [Related]
4. Are needle-free injections a useful alternative for growth hormone therapy in children? Safety and pharmacokinetics of growth hormone delivered by a new needle-free injection device compared to a fine gauge needle.
Dörr HG; Zabransky S; Keller E; Otten BJ; Partsch CJ; Nyman L; Gillespie BK; Lester NR; Wilson AM; Hyrén C; van Kuijck MA; Schuld P; Schoenfeld SL
J Pediatr Endocrinol Metab; 2003 Mar; 16(3):383-92. PubMed ID: 12705363
[TBL] [Abstract][Full Text] [Related]
5. Delivery of insulin by jet injection: recent observations.
Bremseth DL; Pass F
Diabetes Technol Ther; 2001; 3(2):225-32. PubMed ID: 11478329
[TBL] [Abstract][Full Text] [Related]
6. Ease of use and preference for a new disposable self-injection pen compared with a reusable pen for administering recombinant human growth hormone: A multicenter, 2-month, single-arm, open-label clinical trial in patient-caregiver dyads.
Hey-Hadavi J; Pleil A; Deeb LC; Fuqua JS; Silverman LA; Reiner B; Newfield R; Rajicic N; Wajnrajch MP; Cara JF
Clin Ther; 2010 Nov; 32(12):2036-47. PubMed ID: 21118739
[TBL] [Abstract][Full Text] [Related]
7. Pharmacokinetics of recombinant human growth hormone administered by cool.click 2, a new needle-free device, compared with subcutaneous administration using a conventional syringe and needle.
Brearley C; Priestley A; Leighton-Scott J; Christen M
BMC Clin Pharmacol; 2007 Oct; 7():10. PubMed ID: 17922895
[TBL] [Abstract][Full Text] [Related]
8. Subcutaneous administration of midazolam: a comparison of the Bioject jet injector with the conventional syringe and needle.
Bennett J; Nichols F; Rosenblum M; Condry J
J Oral Maxillofac Surg; 1998 Nov; 56(11):1249-54. PubMed ID: 9820211
[TBL] [Abstract][Full Text] [Related]
9. Norditropin SimpleXx: a liquid human growth hormone formulation, a pen system and an auto-insertion device.
Müller J; Skakkebaek NE; Jacobsen BB; Keller E; Heinrich U; Hartmann K; Hokken-Koelega AC; Delemarre van de Waal HA
Horm Res; 1999; 51 Suppl 3():109-12. PubMed ID: 10592453
[TBL] [Abstract][Full Text] [Related]
10. [Anesthesia with jet injection. Use of Medi-Jector EZ dermojet for anesthesia in minor surgery].
Reimer S
Tidsskr Nor Laegeforen; 1994 May; 114(14):1627-9. PubMed ID: 8079268
[TBL] [Abstract][Full Text] [Related]
11. Insulin pen needles: effects of extra-thin wall needle technology on preference, confidence, and other patient ratings.
Aronson R; Gibney MA; Oza K; Bérubé J; Kassler-Taub K; Hirsch L
Clin Ther; 2013 Jul; 35(7):923-933.e4. PubMed ID: 23790553
[TBL] [Abstract][Full Text] [Related]
12. Optimum method for administration of biosynthetic human growth hormone: a randomised crossover trial of an Auto Injector and a pen injection system.
Stanhope R; Albanese A; Moyle L; Hamill G
Arch Dis Child; 1992 Aug; 67(8):994-7. PubMed ID: 1520018
[TBL] [Abstract][Full Text] [Related]
13. Ease of use and acceptability of a new pen device for the administration of growth hormone therapy in pediatric patients: an open-label, uncontrolled usability test.
Fuchs GS; Mikkelsen S; Knudsen TK; Kappelgaard AM
Clin Ther; 2009 Dec; 31(12):2906-14. PubMed ID: 20110030
[TBL] [Abstract][Full Text] [Related]
14. Visualization of injection depot after subcutaneous administration by syringe and needle-free device (Medi-Jector): first results with magnetic resonance imaging.
Partsch CJ; von Büren E; Kühn B; Sippell WG; Brinkmann G
Eur J Pediatr; 1997 Nov; 156(11):893-4. PubMed ID: 9392409
[No Abstract] [Full Text] [Related]
15. Psychometric assessment of the Injection Pen Assessment Questionnaire (IPAQ): measuring ease of use and preference with injection pens for human growth hormone.
Pleil AM; Kimel M; McCormack J; Rajicic N; Hey-Hadavi J
Health Qual Life Outcomes; 2012 Oct; 10():126. PubMed ID: 23046797
[TBL] [Abstract][Full Text] [Related]
16. Pharmacokinetics and pharmacodynamics of a new formulation of recombinant human growth hormone administered by ZomaJet 2 Vision, a new needle-free device, compared to subcutaneous administration using a conventional syringe.
Agersø H; Møller-Pedersen J; Cappi S; Thomann P; Jesussek B; Senderovitz T
J Clin Pharmacol; 2002 Nov; 42(11):1262-8. PubMed ID: 12412826
[TBL] [Abstract][Full Text] [Related]
17. Prefilled pen versus prefilled syringe: a pilot study evaluating two different methods of methotrexate subcutaneous injection in patients with JIA.
Roszkiewicz J; Swacha Z; Smolewska E
Pediatr Rheumatol Online J; 2020 Aug; 18(1):64. PubMed ID: 32787934
[TBL] [Abstract][Full Text] [Related]
18. Comparison of insulin levels after injection by jet stream and disposable insulin syringe.
Malone JI; Lowitt S; Grove NP; Shah SC
Diabetes Care; 1986; 9(6):637-40. PubMed ID: 3542456
[TBL] [Abstract][Full Text] [Related]
19. A comparison of insulin injection needles on patients' perceptions of pain, handling, and acceptability: a randomized, open-label, crossover study in subjects with diabetes.
McKay M; Compion G; Lytzen L
Diabetes Technol Ther; 2009 Mar; 11(3):195-201. PubMed ID: 19267582
[TBL] [Abstract][Full Text] [Related]
20. Synergistic effect of formulated plasmid and needle-free injection for genetic vaccines.
Anwer K; Earle KA; Shi M; Wang J; Mumper RJ; Proctor B; Jansa K; Ledebur HC; Davis S; Eaglstein W; Rolland AP
Pharm Res; 1999 Jun; 16(6):889-95. PubMed ID: 10397610
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
